DRGYX Mutual Fund

DRGYX Mutual Fund

NAV$58.76
See how much of DRGYX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$1.3B
Expense Ratio
0.63%
Dividend Yield (Current)
0.42%
Holdings
92
Inception Date
Jul 1, 2013
Fund Family
BNY Mellon Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+15.22%
1 Year+22.06%
3 Year+19.42%
5 Year+13.55%
10 Year+12.85%

Asset Allocation

Stocks: 97.15%
Bonds: 1.66%
Cash: 0.65%
Other: 0.55%
See how much of DRGYX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
AMZNAmazon.Com Inc6.08%
MSFTMicrosoft Corp5.09%
JPMJpmorgan Chase4.02%
SLBSchlumberger Nv.2.92%
JNJJohnson & Johnson - Common2.73%
Top 10 Concentration: 33.05%Report Date: Aug 31, 2026
Download all 92 holdings for DRGYX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.42%
Latest Distribution
$8.94
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

DRGYX Mutual Fund Overview

DRGYX Mutual Fund (BNY Mellon Dynamic Value Fund Class Y) is managed by BNY Mellon Investment Management with $1.34B in net assets. DRGYX expense ratio is 0.63%, holding 92 positions across sectors including Information Technology, Financials, Health Care. Inception date: 2013-07-01.

DRGYX performance shows a YTD return of 15.22%. The 1-year return is 22.06% and the 5-year return is 13.55%. DRGYX dividend yield stands at 0.42%.

DRGYX top holdings include Amazon.Com Inc (6.1%), Microsoft Corp (5.1%), Jpmorgan Chase (4.0%), Schlumberger Nv. (2.9%), Johnson & Johnson - Common (2.7%). Go to all DRGYX holdings, DRGYX sectors, or DRGYX dividends.

DRGYX can be compared against other funds. Use DRGYX overlap to find shared positions, or DRGYX vs another fund for a side-by-side view. DRGYX alternatives are available via the screener, along with tax-loss harvesting opportunities.